TSND
XTSE
Market cap111mUSD
Nov 20, Last price
0.43CAD
1D
-12.24%
1Q
-50.57%
IPO
-59.05%
Name
Terrascend Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. In addition to its core cannabis operations, the firm also develops and supplies hemp-derived wellness items to retail outlets and crafts specialty cannabis-infused edibles. It further expands its market presence by managing a network of retail dispensaries under The Apothecarium brand name in California, Pennsylvania, and New Jersey. The company's portfolio encompasses various integrated businesses and brands, including Gage Growth, Pinnacle, Ilera Healthcare, Valhalla Confections, State Flower, and Arise Bioscience Inc., among others. Established in 2017, TerrAscend maintains its corporate headquarters in Mississauga, Canada.
Key people
Jason Wild
Executive Chairman of the Board · since 2017
Ziad Ghanem
President, Chief Executive Officer · since 2023
Keith Stauffer
Chief Financial Officer · since 2020
Lynn Gefen
Chief People and Legal Officer, Corporate Secretary · since 2024
Lead Independent Director · since 2021
Kara Dioguardi
Independent Director · since 2022
Ira Duarte
Independent Director · since 2022
Independent Director · since 2024
Headquarters & legal address
77 City Centre Drive Road, Suite 501
Mississauga, ON L5B 1M5
CA
Mississauga, ON L5B 1M5
CA
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||